Abstract
The objective of the present study was to evaluate the sensitivity and efficiency of the matrix metalloproteinase‐9 (MMP‐9) test kit for the diagnosis of bacterial peritonitis in patients undergoing peritoneal dialysis (PD). Peritoneal effluents were collected from seven continuous ambulatory PD (CAPD) patients with peritonitis, four patients with suspected peritonitis, 30 maintenance PD patients without infection, and seven patients at initiation of PD. The MMP‐9 test kit was used to analyze 112 peritoneal effluent samples. These peritoneal effluents were also used to count leukocytes and examine microorganisms. MMP expression was measured by gelatin zymography, and activities were measured by an enzyme‐linked immunosorbent assay (ELISA). The relationship between the reactivity of the test kit and the number of leukocytes in the samples was examined. There was a significant difference in the number of leukocytes in peritoneal effluents between the negative and positive groups detected by the MMP‐9 test kit (P<0.0001). The results obtained with the MMP‐9 test kit were negative for peritoneal effluent samples that did not show increased cell counts. The reactivity of the MMP‐9 test kit showed no significant differences among various microorganisms, and remained stable. The MMP‐9 test kit appears to be a simple and reliable method for early diagnosis of CAPD peritonitis, and reflects the leukocyte count in peritoneal effluents. J. Clin. Lab. Anal. 18:224–230, 2004. © 2004 Wiley‐Liss, Inc.
Keywords: continuous ambulatory peritoneal dialysis, peritonitis matrix metalloproteinases, peritoneal effluent, Leukostix®
REFERENCES
- 1. Keane WF, Alexander SR, Bailie GR, et al. Peritoneal dialysis‐related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996;16:557–573. [PubMed] [Google Scholar]
- 2. Dobbie JW. Ultrastructure and pathology of the peritoneum in peritoneal dialysis In: Gokal R, Nolph KD, editors. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers; 1994. p 14–44. [Google Scholar]
- 3. Dobbie JW, Anderson JD, Hind C. Long‐term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1994;14(suppl 3):16–20. [PubMed] [Google Scholar]
- 4. Oules R, Challah S, Brunner FP. Case‐control study to determine the course of sclerosing peritoneal disease. Nephrol Dial Transplant 1998;3:66–69. [PubMed] [Google Scholar]
- 5. Slingeneyer A, Canoud B, Mion C. Permanent loss of ultrafiltration capacity of the peritoneum in long‐term peritoneal dialysis: an epidemiological study. Nephron 1983;33:133–138. [DOI] [PubMed] [Google Scholar]
- 6. Fukudome K, Fujimoto S, Sato Y, et al. Peritonitis increases MMP‐9 activity in peritoneal effluent from CAPD patients. Nephron 2001;87:35–41. [DOI] [PubMed] [Google Scholar]
- 7. Marshall BC, Santana A, Xu QP, et al. Metalloproteinases and tissue inhibitor of metalloproteinases in human peritoneal mesothelial cells. J Clin Invest 1993;91:1792–1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Ro Y, Hamada C, Tomino Y, et al. Early diagnosis of CAPD peritonitis using a new test kit for detection of matrix metalloproteinase (MMP)‐9. Perit Dial Int 2004.24.7. [PubMed]
- 9. Kossakowska AE, Edwards DR, Lee SS, et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 1998;153:1895–1902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Fujimoto N, Hosokawa N, Hayakawa T, et al. A one‐step sandwich enzyme immunoassay for human matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1994;231:79–88. [DOI] [PubMed] [Google Scholar]
- 11. Jackson DS, Brown AD, Powers JC, et al. A kinetic study of the hydrolysis of the N‐tosylalanine ester of 3‐hydroxy‐5‐phenylpyrrole and related compounds by human leukocyte elastase. Arch Biochem Biophys 1995;323:108–114. [DOI] [PubMed] [Google Scholar]
- 12. Skjold AC, Hugel H. A new dip‐and‐read test for leukocyte esterase activity in urine with the Ames Leukostix® reagent strip. Clin Chem 1985;31:993. [Google Scholar]
- 13. Pendergrass JH, Skjold AC, Stover LR, et al. A control system for monitoring the performance of leukocyte strip tests. Clin Chem 1986;32:1400–1402. [PubMed] [Google Scholar]
- 14. Scheer WD. The detection of leukocyte esterase activity in urine with a new reagent strip. Am J Clin Pathol 1987;87:86–93. [DOI] [PubMed] [Google Scholar]
- 15. William FK, George RB, Stephen V, et al. Adult peritoneal dialysis‐related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000;20:396–411. [PubMed] [Google Scholar]
- 16. Saito K, Hamada C, Tomino Y, et al. Early diagnosis of CAPD peritonitis by a test kit for detecting leukocyturia (Leukostix®). J Jap Soc Dial Ther 1991;24:913–917. [Google Scholar]